TY - JOUR
T1 - Exercise-Induced Pulmonary Hypertension
T2 - Translating Pathophysiological Concepts Into Clinical Practice
AU - Naeije, Robert
AU - Saggar, Rajeev
AU - Badesch, David
AU - Rajagopalan, Sanjay
AU - Gargani, Luna
AU - Rischard, Franz
AU - Ferrara, Francesco
AU - Marra, Alberto M.
AU - D’ Alto, Michele
AU - Bull, Todd M.
AU - Saggar, Rajan
AU - Grünig, Ekkehard
AU - Bossone, Eduardo
N1 - Publisher Copyright:
© 2018 American College of Chest Physicians
PY - 2018/7
Y1 - 2018/7
N2 - Exercise stress testing of the pulmonary circulation for the diagnosis of latent or early-stage pulmonary hypertension (PH) is gaining acceptance. There is emerging consensus to define exercise-induced PH by a mean pulmonary artery pressure > 30 mm Hg at a cardiac output < 10 L/min and a total pulmonary vascular resistance> 3 Wood units at maximum exercise, in the absence of PH at rest. Exercise-induced PH has been reported in association with a bone morphogenetic receptor-2 gene mutation, in systemic sclerosis, in left heart conditions, in chronic lung diseases, and in chronic pulmonary thromboembolism. Exercise-induced PH is a cause of decreased exercise capacity, may precede the development of manifest PH in a proportion of patients, and is associated with a decreased life expectancy. Exercise stress testing of the pulmonary circulation has to be dynamic and rely on measurements of the components of the pulmonary vascular equation during, not after exercise. Noninvasive imaging measurements may be sufficiently accurate in experienced hands, but suffer from lack of precision, so that invasive measurements are required for individual decision-making. Exercise-induced PH is caused either by pulmonary vasoconstriction, pulmonary vascular remodeling, or by increased upstream transmission of pulmonary venous pressure. This differential diagnosis is clinical. Left heart disease as a cause of exercise-induced PH can be further ascertained by a pulmonary artery wedge pressure above or below 20 mm Hg at a cardiac output < 10 L/min or a pulmonary artery wedge pressure-flow relationship above or below 2 mm Hg/L/min during exercise.
AB - Exercise stress testing of the pulmonary circulation for the diagnosis of latent or early-stage pulmonary hypertension (PH) is gaining acceptance. There is emerging consensus to define exercise-induced PH by a mean pulmonary artery pressure > 30 mm Hg at a cardiac output < 10 L/min and a total pulmonary vascular resistance> 3 Wood units at maximum exercise, in the absence of PH at rest. Exercise-induced PH has been reported in association with a bone morphogenetic receptor-2 gene mutation, in systemic sclerosis, in left heart conditions, in chronic lung diseases, and in chronic pulmonary thromboembolism. Exercise-induced PH is a cause of decreased exercise capacity, may precede the development of manifest PH in a proportion of patients, and is associated with a decreased life expectancy. Exercise stress testing of the pulmonary circulation has to be dynamic and rely on measurements of the components of the pulmonary vascular equation during, not after exercise. Noninvasive imaging measurements may be sufficiently accurate in experienced hands, but suffer from lack of precision, so that invasive measurements are required for individual decision-making. Exercise-induced PH is caused either by pulmonary vasoconstriction, pulmonary vascular remodeling, or by increased upstream transmission of pulmonary venous pressure. This differential diagnosis is clinical. Left heart disease as a cause of exercise-induced PH can be further ascertained by a pulmonary artery wedge pressure above or below 20 mm Hg at a cardiac output < 10 L/min or a pulmonary artery wedge pressure-flow relationship above or below 2 mm Hg/L/min during exercise.
KW - exercise-induced pulmonary hypertension
KW - pathophysiology
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85046142572&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046142572&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2018.01.022
DO - 10.1016/j.chest.2018.01.022
M3 - Article
C2 - 29382472
AN - SCOPUS:85046142572
SN - 0012-3692
VL - 154
SP - 10
EP - 15
JO - CHEST
JF - CHEST
IS - 1
ER -